1047 related articles for article (PubMed ID: 19627999)
1. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administration.
Parmentier-Batteur S; O'Brien JA; Doran S; Nguyen SJ; Flick RB; Uslaner JM; Chen H; Finger EN; Williams TM; Jacobson MA; Hutson PH
Neuropharmacology; 2012 Mar; 62(3):1453-60. PubMed ID: 21112344
[TBL] [Abstract][Full Text] [Related]
4. Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats.
Haberny SL; Carr KD
Neuroscience; 2005; 132(4):1035-43. PubMed ID: 15857708
[TBL] [Abstract][Full Text] [Related]
5. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models.
Kinney GG; O'Brien JA; Lemaire W; Burno M; Bickel DJ; Clements MK; Chen TB; Wisnoski DD; Lindsley CW; Tiller PR; Smith S; Jacobson MA; Sur C; Duggan ME; Pettibone DJ; Conn PJ; Williams DL
J Pharmacol Exp Ther; 2005 Apr; 313(1):199-206. PubMed ID: 15608073
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms.
Wu K; Len GW; McAuliffe G; Ma C; Tai JP; Xu F; Black IB
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):178-86. PubMed ID: 15519688
[TBL] [Abstract][Full Text] [Related]
7. Memory consolidation induces N-methyl-D-aspartic acid-receptor- and Ca2+/calmodulin-dependent protein kinase II-dependent modifications in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor properties.
Bevilaqua LR; Medina JH; Izquierdo I; Cammarota M
Neuroscience; 2005; 136(2):397-403. PubMed ID: 16182449
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
[TBL] [Abstract][Full Text] [Related]
9. Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes.
de Paulis T; Hemstapat K; Chen Y; Zhang Y; Saleh S; Alagille D; Baldwin RM; Tamagnan GD; Conn PJ
J Med Chem; 2006 Jun; 49(11):3332-44. PubMed ID: 16722652
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.
Clifton NE; Morisot N; Girardon S; Millan MJ; Loiseau F
Psychopharmacology (Berl); 2013 Feb; 225(3):579-94. PubMed ID: 22983144
[TBL] [Abstract][Full Text] [Related]
11. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
Moriguchi S; Han F; Shioda N; Yamamoto Y; Nakajima T; Nakagawasai O; Tadano T; Yeh JZ; Narahashi T; Fukunaga K
J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128
[TBL] [Abstract][Full Text] [Related]
12. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice.
Horio M; Fujita Y; Hashimoto K
Fundam Clin Pharmacol; 2013 Oct; 27(5):483-8. PubMed ID: 22594375
[TBL] [Abstract][Full Text] [Related]
14. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.
Yamamoto Y; Shioda N; Han F; Moriguchi S; Nakajima A; Yokosuka A; Mimaki Y; Sashida Y; Yamakuni T; Ohizumi Y; Fukunaga K
Brain Res; 2009 Oct; 1295():218-29. PubMed ID: 19646972
[TBL] [Abstract][Full Text] [Related]
15. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.
Lecourtier L; Homayoun H; Tamagnan G; Moghaddam B
Biol Psychiatry; 2007 Oct; 62(7):739-46. PubMed ID: 17511968
[TBL] [Abstract][Full Text] [Related]
16. 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade.
Al Rahim M; Nakajima A; Saigusa D; Tetsu N; Maruyama Y; Shibuya M; Yamakoshi H; Tomioka Y; Iwabuchi Y; Ohizumi Y; Yamakuni T
Biochemistry; 2009 Aug; 48(32):7713-21. PubMed ID: 19601643
[TBL] [Abstract][Full Text] [Related]
17. MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia?
Vardigan JD; Huszar SL; McNaughton CH; Hutson PH; Uslaner JM
Pharmacol Biochem Behav; 2010 Apr; 95(2):223-9. PubMed ID: 20122952
[TBL] [Abstract][Full Text] [Related]
18. Effects of MK-801 and CNQX on various neurotoxic responses induced by kainic acid in mice.
Lee JK; Choi SS; Lee HK; Han KJ; Han EJ; Suh HW
Mol Cells; 2002 Dec; 14(3):339-47. PubMed ID: 12521295
[TBL] [Abstract][Full Text] [Related]
19. Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs.
Fumagalli F; Frasca A; Racagni G; Riva MA
Mol Pharmacol; 2008 May; 73(5):1484-90. PubMed ID: 18250147
[TBL] [Abstract][Full Text] [Related]
20. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
Moriguchi S; Shioda N; Han F; Narahashi T; Fukunaga K
J Neurochem; 2008 Aug; 106(3):1092-103. PubMed ID: 18445137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
